GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...
The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results